(1-Benzylpiperidin-4-yl)methanamine

Catalog No.: 
ACAYIE079
CAS No.: 
88915-26-8
Molecular Formula: 
C13H20N2
Molecular Weight: 
204.32
(1-Benzylpiperidin-4-yl)methanamine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g95%$94.00In stockIn stock
10g95%$145.00In stockIn stock
25g95%$358.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(1-Benzylpiperidin-4-yl)methanamine
IUPAC Name(1-benzylpiperidin-4-yl)methanamine
MDL No.MFCD04116211
Molecular FormulaC13H20N2
Molecular Weight204.32
SMILESNCC1CCN(CC2=CC=CC=C2)CC1
InChI KeyKNUKUWNSGVICSX-UHFFFAOYSA-N
Synonym4-PIPERIDINEMETHANAMINE, 1-(PHENYLMETHYL)-;4-AMINOMETHYL-1-BENZYLPIPERIDINE;AKOS B029940;1-BENZYL-PIPERIDIN-4-METHYLAMINE;[(1-BENZYLPIPERIDIN-4-YL)METHYL]AMINE;(1-BENZYL-4-PIPERIDINYL)METHYLAMINE;CHEMBRDG-BB 4009650;C-(1-BENZYL-PIPERIDIN-4-YL)-METHYLAMINE
CAS No.88915-26-8
PubChem CID1514444

Safety Data

Pictogram
Corrosive
Signal Word
Danger
Hazard Statement(s)
H314
Precautionary Statement(s)
P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACAYIE079 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACABFV549 route compound structure diagram
    ACABFV54962718-31-4In Stock
  2. Then
  3. ACAYIE079 route product structure diagram
    ACAYIE07988915-26-8In Stock
Inquiry

2. ACAYIE079 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACPEFY594 route compound structure diagram
    ACPEFY59462992-68-1In Stock
  2. Then
  3. ACAYIE079 route product structure diagram
    ACAYIE07988915-26-8In Stock
Inquiry

3. ACAYIE079 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACAYIE079 route product structure diagram
    ACAYIE07988915-26-8In Stock
Inquiry

Comments (0)